Prism Ideas represents the highest standards in scientific service provision for the pharmaceutical industry in the areas of drug and diagnostic development and medical communications. Our team of physicians and scientists, many of whom have extensive experience within the pharmaceutical industry, provide seamless support from drug development to commercialisation.
Established in 2001, Prism has delivered projects for a global client base of around 40 different pharmaceutical companies. Our clients include 5 of the top 10 pharmaceutical companies, as well as a broad range of smaller pharmaceutical companies and biotechs from Europe, USA, Japan and Australia.
Our services are focused on those that benefit from the contribution of medical expertise. In practice this represents a spectrum of activities that can be placed into three broad categories:
• Clinical development
• Drug safety services
• Medical communications
Prism is unique in the blend of skills we offer. Experts in clinical development, medical affairs and publications all contribute to us being able to place ourselves in our clients’ shoes and add value at every level.
Our team comprises experts in the design of clinical development plans as well as individual clinical trials from Phase I to Phase IV, drug safety evaluation and reporting, publication planning and medical communications, advisory boards, HTA submissions and promotional copy review.
Our expertise encompasses a broad range of therapy areas including oncology, virology, haematology, anaesthesia, diagnostics, respiratory medicine, infection, sexual health, neurology, hypertension, allergy and paediatrics.
Prism has a global client base ranging from top 10 pharmaceutical companies to small biotechs